Konstantin Fest
Head of Investor Relations, GSK
Replay available
GSK plc (GSK) Q1 2025 Earnings Call
GSK plc (NYSE: GSK) Q1 2025 earnings conference call, held 2025-04-30. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Emma Walmsley
Chief Executive Officer, GSK
Luke Miles
President, Pharmaceuticals, GSK
David Redfern
Chairman, ViiV Healthcare
Julie Brown
Chief Financial Officer, GSK
Tony Wood
Chief Scientific Officer, GSK
Terry Hall Ford
Analyst, Berenberg
James Gordon
Analyst, JP Morgan
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Gsk Plc.
Replay transcript excerpt
WEBVTT 00:00:00.000 -- 00:00:05.600 and gentlemen, a very warm welcome to this GSK Q1 2025 00:00:05.600 -- 00:00:07.740 results call. 00:00:07.740 -- 00:00:13.020 My name is Konstantin Fest, new head of IR at GSK, and I'm delighted 00:00:13.020 -- 00:00:18.420 to be joined today by Emma Warmsley, Luke Miles, and Julie Brown. 00:00:18.420 -- 00:00:24.360 I'm pleased to say Deborah Waterhouse, CEO of Veev, returned this week full-time, 00:00:24.360 -- 00:00:29.080 but David Redfern, chairman of Veev, will be covering HIV today. 00:00:29.080 -- 00:00:34.500 Tony Wood, our CSO, will also be joining us for Q&A. 00:00:34.500 -- 00:00:39.020 Today's call will last approximately one hour, with the presentation taking around 30 00:00:39.020 -- 00:00:43.540 minutes and the remaining time for your questions. 00:00:43.660 -- 00:00:49.780 Please ask only one to two questions so that everyone has a chance to participate. 00:00:49.960 -- 00:00:54.140 Before we start, please turn to slide 3. 00:00:54.140 -- 00:00:58.260 This is the usual safe harbor statement. 00:00:58.260 -- 00:01:03.580 We will comment on our performance using constant exchange rates, or CER, unless 00:01:03.580 -- 00:01:05.780 otherwise stated. 00:01:05.780 -- 00:01:10.240 I will now hand over to Emma on slide 4. 00:01:10.260 -- 00:01:13.600 Thank you, Konstantin, and it's great to have you on board. 00:01:13.600 -- 00:01:16.360 And welcome to everybody joining us today. 00:01:16.360 -- 00:01:19.280 Please turn to the next slide. 00:01:19.480 -- 00:01:24.560 GSK continues to make strong progress. Group sales were up 4% 00:01:24.560 -- 00:01:29.680 this quarter, core operating profit grew 5%, and core earnings per share also 00:01:29.680 -- 00:01:34.700 rose 5% to 44.9 pence. This performance was in line with 00:0...